{"id":142974,"date":"1993-01-01T00:00:00","date_gmt":"1993-01-01T00:00:00","guid":{"rendered":"https:\/\/www.deberes.net\/tesis\/sin-categoria\/influencia-del-tratamiento-con-eritropoyetina-sobre-la-calidad-de-vida-de-los-pacientes-con-insuficiencia-renal-cronica-en-hemodialisis\/"},"modified":"1993-01-01T00:00:00","modified_gmt":"1993-01-01T00:00:00","slug":"influencia-del-tratamiento-con-eritropoyetina-sobre-la-calidad-de-vida-de-los-pacientes-con-insuficiencia-renal-cronica-en-hemodialisis","status":"publish","type":"post","link":"https:\/\/www.deberes.net\/tesis\/ciencias-medicas\/influencia-del-tratamiento-con-eritropoyetina-sobre-la-calidad-de-vida-de-los-pacientes-con-insuficiencia-renal-cronica-en-hemodialisis\/","title":{"rendered":"Influencia del tratamiento con eritropoyetina sobre la calidad de vida de los pacientes con insuficiencia renal cronica en hemodialisis."},"content":{"rendered":"<h2>Tesis doctoral de <strong> Fuensanta Moreno Barrio <\/strong><\/h2>\n<p>En pacientes en dialisis con anemia severa que iniciaban tratamiento con eritropoyetina se ha valorado la calidad de vida mediante elsickness impac profile y la escala de karnofpky, evidenciandose una importante mejoria de la calidad de vida segun estos indicadores. Mientras que en un grupo control de pacientes en hemodialisis sin anemia importante la calidad de vida ha permanecido estable sin cambios significativos. Se han valorado los factores relacionados con la calidad de vida de los pacientes al inicio del estudio y con la mejoria de calidad de vida tras el tratamiento con eritropoyetina. Tambien se ha demostrado que los pacientes seniles retoman un grado similar a los mas jovenes tras recibir eritropoyetina.<\/p>\n<p>&nbsp;<\/p>\n<h3>Datos acad\u00e9micos de la tesis doctoral \u00ab<strong>Influencia del tratamiento con eritropoyetina sobre la calidad de vida de los pacientes con insuficiencia renal cronica en hemodialisis.<\/strong>\u00ab<\/h3>\n<ul>\n<li><strong>T\u00edtulo de la tesis:<\/strong>\u00a0 Influencia del tratamiento con eritropoyetina sobre la calidad de vida de los pacientes con insuficiencia renal cronica en hemodialisis. <\/li>\n<li><strong>Autor:<\/strong>\u00a0 Fuensanta Moreno Barrio <\/li>\n<li><strong>Universidad:<\/strong>\u00a0 Complutense de Madrid<\/li>\n<li><strong>Fecha de lectura de la tesis:<\/strong>\u00a0 01\/01\/1993<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h3>Direcci\u00f3n y tribunal<\/h3>\n<ul>\n<li><strong>Director de la tesis<\/strong>\n<ul>\n<li>Fernando Valderrabano Quintana<\/li>\n<\/ul>\n<\/li>\n<li><strong>Tribunal<\/strong>\n<ul>\n<li>Presidente del tribunal: Rafael Alcala-santaella Nu\u00f1ez <\/li>\n<li>J. Botella Garcia (vocal)<\/li>\n<li>Carlos Perezagua Clamagirand (vocal)<\/li>\n<li>J. Egido Rios (vocal)<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tesis doctoral de Fuensanta Moreno Barrio En pacientes en dialisis con anemia severa que iniciaban tratamiento con eritropoyetina se ha [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[9,986,139,179],"tags":[23249,7024,257711,257712,257713,257199],"class_list":["post-142974","post","type-post","status-publish","format-standard","hentry","category-ciencias-medicas","category-complutense-de-madrid","category-medicina-interna","category-nefrologia","tag-carlos-perezagua-clamagirand","tag-fernando-valderrabano-quintana","tag-fuensanta-moreno-barrio","tag-j-botella-garcia","tag-j-egido-rios","tag-rafael-alcala-santaella-nunez"],"_links":{"self":[{"href":"https:\/\/www.deberes.net\/tesis\/wp-json\/wp\/v2\/posts\/142974","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.deberes.net\/tesis\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.deberes.net\/tesis\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.deberes.net\/tesis\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.deberes.net\/tesis\/wp-json\/wp\/v2\/comments?post=142974"}],"version-history":[{"count":0,"href":"https:\/\/www.deberes.net\/tesis\/wp-json\/wp\/v2\/posts\/142974\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.deberes.net\/tesis\/wp-json\/wp\/v2\/media?parent=142974"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.deberes.net\/tesis\/wp-json\/wp\/v2\/categories?post=142974"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.deberes.net\/tesis\/wp-json\/wp\/v2\/tags?post=142974"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}